A new hybrid vehicle is under development. Its performance isn’t measured by the distance...
An interdisciplinary team of scientists has convened to map the origins of mental...
Merck & Co., a top creator and seller of vaccines, has joined the fight against Ebola, the often-fatal hemorrhagic virus that's been ravaging parts of West Africa for months.
Guided by breakthrough research on the Estrogen Receptor 1 (ESR1) gene, many researchers and pharmaceutical companies are in hot pursuit of the next big anti-resistance breast cancer drug.
Research shows that taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward. The benefits seem to grow over time and may last for life.
A team of researchers have used a laser beam trap to examine how drug particles from asthma inhalers behave as they are projected through the air. Their findings could improve the effectiveness of inhalers for the over five million people in the UK suffering from asthma.
A top official with the U.N. health agency says few experimental therapies are currently under development that could effectively treat Ebola.
Chris Viehbacher, the high-flying pharma executive, had his career with Sanofi derailed for a variety of surprising factors. Here's a look at the odd ouster of the former CEO.
Scientists have discovered gene mutations that give people naturally lower cholesterol levels and cut their risk of heart disease in half. That discovery may have a big implication for a blockbuster heart drug.
A novel method of altering a protein in milk to bind with an antiretroviral drug promises to greatly improve treatment for infants and young children suffering from HIV/AIDS, according to new research.
After months of delayed, fragmented responses, the international medical community recognized Ebola as a threat to global health security. Here’s where the situation stands today as well as questions raised and lessons learned.
The nasal spray version of the flu vaccine did not protect young children against swine flu last winter and might not work again this year, health officials said Thursday.
Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study has found. The findings suggest a possible link between body fat and the risk of toxicity from some types of immunotherapy.
A new study has identified a potential target for therapies to treat cocaine addiction. Investigators found evidence that changing one amino acid in a subunit of an important receptor protein alters whether cocaine-experienced animals will resume drug seeking after a period of cocaine abstinence.
Radiotherapy is a primary, adjuvant or neoadjuvant treatment for a number of different cancers, such as glioblastoma, breast, lung and prostate. Image-guided radiation therapy (IGRT) is used to reduce the amount of radiation delivered to the normal tissue surrounding the targeted tumor. However, in the preclinical setting, the use of IGRT is less common.
Digoxin, a medication used in the treatment of heart failure, may be adaptable for the treatment of amyotrophic lateral sclerosis (ALS), a progressive, paralyzing disease, suggests new research.
As more states legalize medical marijuana, there's one stage in the process nobody wants to talk about: the part where people still have to break the law.
The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.
Physicians will tell you: They are not winning the war on ovarian cancer. But researchers have combined medicine and advanced nanotechnological engineering to create a smarter, more targeted therapy that could overcome the most lethal gynecologic cancer.
Scientists have uncovered details about how cancer is able to become drug resistant over time, a phenomenon that occurs because cancer cells within the same tumor aren’t identical.
A drug being studied as a fast-acting mood-lifter restored pleasure-seeking behavior independent of— and ahead of— its other antidepressant effects, in an NIH trial.
Researchers have found a way to kill prostate cancer cells by delivering a trove of copper along with a drug that selectively destroys the diseased cells brimming with the mineral, leaving non-cancer cells healthy.
A Dallas nurse being treated for Ebola has received a plasma transfusion from a doctor who beat his own infection with the deadly virus after getting a similar treatment. The reason: Antibodies in the blood of a survivor may help a patient fight off the germ.
Lethal fibrosis in lungs of mice with idiopathic pulmonary fibrosis (IPF) can be reversed, say researchers. No drug on the market can do this. But the crew pulled it off, in mice, by temporarily restoring (a mimic of) one of the body’s own anti-fibrosis agents, sharply reduced in IPF: microRNA-29.
Results of a small clinical trial suggest that a chemical derived from broccoli sprouts— and best known for claims that it can help prevent certain cancers— may ease classic behavioral symptoms in those with autism spectrum disorders (ASDs).
A research team has used high-resolution cryo-electron microscopy to obtain novel insights into the ultrastructural changes in an intracellular machine associated with the acquisition of resistance to the antibiotic erythromycin.
- Page 1